Additionally, exploring the utility of Mets-IR for risk stratification and for guiding targeted interventions—such as lifestyle modifications or the use of insulin sensitizers in specific PCOS subphenotypes—represents a promising direction for personalized medicine. The gene discussed is INS; the disease is polycystic ovary syndrome.